Lv3
360 积分 2024-05-10 加入
Estimands, Estimators, and Estimates
2个月前
已完结
PCSK9-directed therapies: an update
9个月前
已完结
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
10个月前
已完结
Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association
10个月前
已完结
Reader response: Lipid levels and the risk of hemorrhagic stroke among women
10个月前
已完结
Author response: Lipid levels and the risk of hemorrhagic stroke among women
10个月前
已完结
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
10个月前
已完结
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
10个月前
已完结
2024 ESC Guidelines for the management of chronic coronary syndromes
11个月前
已完结
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
11个月前
已完结
皖公网安备34019202002308
